{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05931276",
            "orgStudyIdInfo": {
                "id": "2026"
            },
            "organization": {
                "fullName": "VA Office of Research and Development",
                "class": "FED"
            },
            "briefTitle": "CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes",
            "officialTitle": "CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes (BRAVO)",
            "acronym": "BRAVO",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "csp-beta-blocker-dialyzability-on-cardiovascular-outcomes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-11-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-03-29",
            "studyFirstSubmitQcDate": "2023-06-26",
            "studyFirstPostDateStruct": {
                "date": "2023-07-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "VA Office of Research and Development",
                "class": "FED"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The investigators aim to determine, using a point-of-care randomized controlled trial design, if hemodialysis patients, who are randomized to metoprolol succinate (a dialyzable, beta-1 selective beta blocker), have an improved cardiovascular outcome compared to those randomized to carvedilol (a non-dialyzable, non-selective beta blocker with alpha-1 antagonist properties). The investigators will also examine intervention practices to identify components that best support engagement and sustainability.",
            "detailedDescription": "Approximately 35,000 Veterans have end stage kidney disease (ESKD) with an incidence of 13,000 annually. These numbers are increasing because of the epidemic of diabetes, the most common cause of ESKD, among the Veteran population. Patients with ESKD on hemodialysis have substantial cardiovascular morbidity. Veterans annual mortality is in excess of 15% and more than half the deaths are due to cardiovascular disease. Beta blockers have been shown to prevent cardiovascular events in randomized clinical trials in patients without chronic kidney disease, particularly those with heart failure and after myocardial infarction. Beta blockers are a mainstay of therapy in dialysis patients, with two-thirds of Veterans on dialysis receiving a beta blocker. There are no head-to-head randomized studies comparing the two most commonly used beta blockers in ESKD patients in the United States, metoprolol and carvedilol, but observational studies suggest superior outcomes for patients treated with metoprolol. The identification of the superior beta blocker may significantly improve the morbidity and mortality of the VA dialysis population.\n\nThe investigators aim to compare two beta blockers with similar indications, usage and availability within the VA but with major differences in patients dialysis clearance and adrenergic effects. The investigators aim to determine if patients undergoing dialysis have improved survival when using metoprolol succinate, a beta blocker that is removed by dialysis and is beta-1 selective, compared to carvedilol, a beta blocker that is not removed by dialysis and is not beta-selective and is also an alpha-blocker."
        },
        "conditionsModule": {
            "conditions": [
                "End-Stage Kidney Disease",
                "End-Stage Renal Disease"
            ],
            "keywords": [
                "Dialysis",
                "beta-Blockers, Adrenergic",
                "Cardiovascular Diseases",
                "Point of Care Research",
                "Comparative Effectiveness Research",
                "Metoprolol Succinate",
                "Carvedilol",
                "Hemodialysis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "The study design is a multicenter clinically integrated prospective randomized open-label blinded-endpoint (PROBE) trial",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 2540,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Metoprolol Succinate",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Depending on baseline type and dose of beta blocker:\n\n* 25 mg once daily (12.5 mg once daily if \\> NYHA class II)\n* 50 mg (or 25 mg) once daily\n* 100 mg (or 50 mg) once daily\n* 200 mg (or 100 mg titrated to 200 mg) once daily",
                    "interventionNames": [
                        "Drug: Metoprolol Succinate"
                    ]
                },
                {
                    "label": "Carvedilol",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Depending on baseline type and dose of beta blocker:\n\n* 3.125 mg twice daily\n* 6.25 mg twice daily\n* 12.5 mg twice daily\n* 25 mg twice daily (may titrate to 5 0mg twice daily if \\> 85 kg)",
                    "interventionNames": [
                        "Drug: Carvedilol"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Metoprolol Succinate",
                    "description": "a dialyzable, beta-1 selective beta blocker",
                    "armGroupLabels": [
                        "Metoprolol Succinate"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Carvedilol",
                    "description": "a non-dialyzable, non-selective beta blocker with alpha-1 antagonist properties",
                    "armGroupLabels": [
                        "Carvedilol"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Time to major cardiovascular event",
                    "description": "The Primary outcome measure will be time to a non-fatal adverse cardiovascular event, defined as a composite outcome comprised of the first occurrence after randomization of any of the following: myocardial infarction, stroke, or hospitalization for heart failure, and all-cause mortality",
                    "timeFrame": "Randomization to time to event; average follow-up 3 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Non-fatal myocardial infarction",
                    "description": "Non-fatal myocardial infarction",
                    "timeFrame": "Randomization to time to event; average follow-up 3 years"
                },
                {
                    "measure": "Non-fatal stroke",
                    "description": "Non-fatal stroke",
                    "timeFrame": "Randomization to time to event; average follow-up 3 years"
                },
                {
                    "measure": "Hospitalization for heart failure",
                    "description": "Hospitalization for heart failure",
                    "timeFrame": "Randomization to time to event; average follow-up 3 years"
                },
                {
                    "measure": "All-cause mortality",
                    "description": "All-cause mortality",
                    "timeFrame": "Randomization to time to event; average follow-up 3 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "All-cause hospitalization",
                    "description": "All-cause hospitalization",
                    "timeFrame": "Randomization to time to event; average follow-up 3 years"
                },
                {
                    "measure": "ED visit or hospitalization possibly related to low BP including falls, fractures, hypotension, or serious injury",
                    "description": "Number of emergency department visits or hospitalization for events that may be a consequence of low blood pressure or beta blocker excess or withdrawal including falls, fractures, hypotension, or serious injury",
                    "timeFrame": "Number of events; average follow-up 3 years"
                },
                {
                    "measure": "Use of BP raising medications",
                    "description": "Use and dose of midodrine",
                    "timeFrame": "Use of drug; average follow-up 3 years"
                },
                {
                    "measure": "ED or hospital visits for atrial fibrillation and uncontrolled rate",
                    "description": "Emergency department visit or hospitalization for atrial fibrillation with uncontrolled rate (to capture poor control with beta blocker withdrawal)",
                    "timeFrame": "Randomization to time to event; average follow-up 3 yars"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Eligible patients are those (including men, women and minorities)\n* On hemodialysis\n* Received one of the following beta blockers through the VA pharmacy prescribed by a VA provider: metoprolol (succinate or tartrate), atenolol, labetalol, carvedilol, bisoprolol, nadolol, pindolol, nebivolol\n\nExclusion Criteria:\n\n* Impaired decision-making capacity\n* Patients not receiving carvedilol who have a history of asthma\n* known hypersensitivity to any component of either drug\n* Provider unwilling to sign a new medication order for a randomized patient\n* No surrogate consent will be allowed",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jade Fiotto",
                    "role": "CONTACT",
                    "phone": "(617) 232-9500",
                    "email": "Jade.Fiotto@va.gov"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Areef Ishani, MD MS",
                    "affiliation": "Minneapolis VA Health Care System, Minneapolis, MN",
                    "role": "STUDY_CHAIR"
                },
                {
                    "name": "James S Kaufman, MD",
                    "affiliation": "VA NY Harbor Healthcare System, New York, NY",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02130-4817",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jade Fiotto, MPH",
                            "role": "CONTACT",
                            "phone": "617-232-9500",
                            "email": "jade.fiotto@va.gov"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Minneapolis VA Health Care System, Minneapolis, MN",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55417-2309",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Areef Ishani, MD MS",
                            "role": "CONTACT",
                            "phone": "612-467-4431",
                            "phoneExt": "314431",
                            "email": "areef.ishani@va.gov"
                        },
                        {
                            "name": "Areef Ishani, MD MS",
                            "role": "STUDY_CHAIR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                },
                {
                    "facility": "VA NY Harbor Healthcare System, New York, NY",
                    "status": "NOT_YET_RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10010-5011",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "James Kaufman, MD",
                            "role": "CONTACT",
                            "email": "james.kaufman@va.gov"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000007676",
                    "term": "Kidney Failure, Chronic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000051436",
                    "term": "Renal Insufficiency, Chronic"
                },
                {
                    "id": "D000051437",
                    "term": "Renal Insufficiency"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10699",
                    "name": "Kidney Failure, Chronic",
                    "asFound": "End Stage Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26718",
                    "name": "Renal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M26717",
                    "name": "Renal Insufficiency, Chronic",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008790",
                    "term": "Metoprolol"
                },
                {
                    "id": "D000077261",
                    "term": "Carvedilol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000013565",
                    "term": "Sympatholytics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000058671",
                    "term": "Adrenergic beta-1 Receptor Antagonists"
                },
                {
                    "id": "D000000319",
                    "term": "Adrenergic beta-Antagonists"
                },
                {
                    "id": "D000018674",
                    "term": "Adrenergic Antagonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000975",
                    "term": "Antioxidants"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000002121",
                    "term": "Calcium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000077264",
                    "term": "Calcium-Regulating Hormones and Agents"
                },
                {
                    "id": "D000014665",
                    "term": "Vasodilator Agents"
                },
                {
                    "id": "D000058668",
                    "term": "Adrenergic alpha-1 Receptor Antagonists"
                },
                {
                    "id": "D000000317",
                    "term": "Adrenergic alpha-Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3671",
                    "name": "Adrenergic beta-Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M1718",
                    "name": "Carvedilol",
                    "asFound": "Cause",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11762",
                    "name": "Metoprolol",
                    "asFound": "Of Part",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M16344",
                    "name": "Sympatholytics",
                    "relevance": "LOW"
                },
                {
                    "id": "M29197",
                    "name": "Adrenergic beta-1 Receptor Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20755",
                    "name": "Adrenergic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4292",
                    "name": "Antioxidants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M5384",
                    "name": "Calcium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M17412",
                    "name": "Vasodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M29194",
                    "name": "Adrenergic alpha-1 Receptor Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M3669",
                    "name": "Adrenergic alpha-Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                }
            ]
        }
    },
    "hasResults": false
}